ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
The sub-analysis, highlighting 12-month Freedom from Major Adverse Events and Major Amputation, supports the value of CSI’s Diamondback 360 ® Peripheral OAS during endovascular intervention for ...
Cardiovascular Systems, Inc. (CSI) a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, ...
Cardiovascular Systems (CSI; St. Paul, Minnesota) is gaining even more headway with its Diamondback 360° System as the device is set to be evaluated in its treatment of coronary arteries. The company ...
Compliance 360 deg results presented by Dr. Raymond Dattilo show superior outcomes at six months for peripheral arterial disease patients treated with CSI's device. St. Paul, MN & San Francisco, CA ...
Investor Relations, 651-259-2800orSarah Wozniak, 651-259-1636orMatt Sullivan, 612-455-1709orDave Folkens, 612-455-1741 Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company ...
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery ...
Cardiovascular Systems Inc. (CSI), based in New Brighton, Minnesota, has raised $5 million from the sale of debt, according to documents filed with the Securities and Exchange Commission. The company, ...
Introduction of Orbital Atherectomy in Canada Expands Treatment Options for Patients with Complex Coronary Artery Disease Dr. Kalra said, “Patients with calcific coronary artery disease can have poor ...
Investor Relations, 651-259-2800orSarah Wozniak, 651-259-1636orMatt Sullivan, 612-455-1709orDave Folkens, 612-455-1741 Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company ...
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and ...
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results